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Overexpression of bovine Fcrn 
in mice enhances T-dependent 
immune responses by amplifying 
T helper cell frequency and 
germinal center enlargement  
in the spleen
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Attila Iliás 1, Judit Cervenak 2, Péter Balogh 3,4, István Kurucz 5 †  and Imre Kacskovics 1,2*
1 Department of Immunology, Eötvös Loránd University, Budapest, Hungary, 2 ImmunoGenes Kft, Budakeszi, Hungary, 
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The neonatal Fc receptor (FcRn) plays key roles in IgG and albumin homeostasis, 
maternal IgG transport, and antigen presentation of IgG-opsonized antigens. Previously, 
we reported that transgenic (Tg) mice that overexpress the bovine FcRn (bFcRn) have 
augmented T-dependent humoral immune response with increased IgG protection, 
higher level of antigen-specific antibodies, greater number of antigen-specific B cells, and 
effective immune response even against weakly immunogenic epitopes. In the current 
study, we analyzed the localization of the bFcRn in secondary lymphoid organs, and 
focused to demonstrate the in vivo impact of its overexpression in the spleen on the 
course of antibody production. bFcRn was highly expressed by red pulp macrophages 
and marginal zone macrophages in the spleen and by subcapsular sinus macrophages 
and macrophage-like cells in the interfollicular areas in the lymph node cortex. We also 
demonstrated that splenic dendritic cells of Tg mice express bFcRn and intraperitoneal 
immunization of these mice with T-dependent antigens led to more than threefold 
increase in the number of antigen-specific activated T helper cells with increased size 
and numbers of germinal centers compared to wild-type controls. bFcRn expression 
in splenic B cells was also detected and that may also contribute to the enhanced B 
cell activation. Finally, we demonstrated that these Tg mice developed efficient immune 
response against very low dose of antigen, reflecting another important practical benefit 
of these Tg mice.
Keywords: Fcrn overexpression, germinal center, humoral immune response, antigen presentation
Abbreviations: Ag, antigen; FcRn, neonatal Fc receptor; GC, germinal center; KLH, keyhole limpet hemocyanin; 
mAb, monoclonal antibody; MZ, marginal zone; Tg, transgenic, wt, wild type.
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introduction
Based on a recent survey, wild-type (wt) mice are the source of 
two-third of all late stage and marketed therapeutic monoclonal 
antibodies (mAbs), primarily in the form of humanized antibod-
ies (1). In recent years, there has been an increasing demand for 
the development of faster and more efficient technologies for 
the production of high-affinity mAbs against specific epitopes of 
targets that are considered to be weakly immunogenic or even 
tolerogenic. Therefore, it is important to increase the efficiency 
of the humoral immune response of the mouse to enhance their 
capability to produce hybridomas against challenging targets.
Although the neonatal Fc receptor (FcRn) was originally identi-
fied as the protein that mediates the maternal immune transport 
(2, 3), it was soon realized that this receptor is a key player in 
regulating the transport of IgG within and across cells of diverse 
origins. Furthermore, FcRn also serves to rescue IgG and albumin 
in capillary endothelial and hematopoietic cells from degradation, 
prolonging their half-lives (4). More recently, FcRn was demon-
strated to play major roles in antigen (Ag) presentation in case of 
Ag–IgG immune complexes (IC) by professional Ag-presenting 
cells (APCs) stimulating MHC class II and also MHC class I-related 
T cell activation (5).
We have previously shown that overexpression of the FcRn in 
transgenic mice and rabbits extended IgG half-life (6, 7). These 
animals develop higher Ag-specific antibody titers, which is not 
merely the result of the better IgG protection but primarily due 
to the increased number of activated Ag-specific B cells, upon 
immunization on the course of T-dependent immune response 
(8–10). We have been able to take advantage of the enhanced 
humoral immune response of these animals by developing high 
quality antibodies against challenging antigens, like against the 
conserved segment of the influenza hemagglutinin subunit 2 or 
the GPCR cannabinoid receptor type 1 (11, 12).
In support of the role of FcRn in Ag presentation in mouse and 
human, we previously demonstrated that the bovine FcRn (bFcRn) 
is expressed in peritoneal macrophages (MΦ) and bone marrow-
derived dendritic cells in bFcRn Tg mice (13). We also confirmed 
that the Tg bone marrow-derived dendritic cells stimulate T helper 
cells significantly more efficiently when loaded with Ag–IgG ICs 
than those derived from wt mice (13). These in vitro data suggested 
that overexpression of the bFcRn in APCs results in augmented Ag 
presentation leading to increased number of Ag-specific B cells in 
the bFcRn Tg mice. Yet, the augmented antigen presentation has 
not been analyzed in the secondary lymphoid organs of these Tg 
mice, and thus the relationship between bFcRn overexpression 
and the increased number of antigen-specific B cells during the 
humoral immune response still had to be confirmed.
Therefore, we first analyzed the architecture of the spleen and 
identified the bFcRn-positive cells in the secondary lymphoid 
organs of the bFcRn Tg mice comparing them to the expression 
pattern of the mouse FcRn (mFcRn) that had been reported for 
phagocytic cells and APCs (14–18). This issue is important as the 
bFcRn expression is regulated by its own regulatory elements in 
these Tg mice (6) that are similar to its mouse and human counter-
parts with some differences. Notably, we found upregulation of the 
bFcRn by NFκB in the spleen and peritoneal MΦs (19) similarly 
to the human FcRn (hFcRn) (20), while this has not been reported 
for the mFcRn (21). Despite the difference of cytokine inducibility, 
mFcRn and hFcRn are considered to be expressed in the same cell 
types and thus mouse is a well-established model for analyzing 
the distribution and function of the hFcRn. Nevertheless, there 
is at least one exception from this general concept as mFcRn is 
expressed only in newborn enterocytes, while hFcRn is expressed 
in these cells throughout life (4), suggesting careful analysis of 
the expression and function of the transgenic bFcRn in these Tg 
mice is salutary.
We also analyzed the Ag presentation efficiency of the splenic 
APCs by immunizing Tg and wt mice with ovalbumin (OVA) and 
studied recall activation of T cells from unsorted splenocytes of 
these mice. Then, we determined germinal center (GC) size distri-
butions and kinetics of their formation in the spleen followed by 
trinitrophenyl (TNP)-KLH immunization. Finally, the efficiency 
of the Ag-specific IgG antibody responses against low-dose antigen 
was evaluated.
Materials and Methods
animals
We used hemizygous transgenic mice that carry five copies of the 
bFcRn α-chain encoding gene (bovine FCGRT) in addition to the 
endogenous mouse FCGRT gene on BALB/c genetic background 
[BALB/c_Tg5_bFCGRT(19); 19 refers to the founder line] that we 
have previously generated (9). Wt BALB/c mice were littermates 
of the transgenic animals resulted from hemizygous breeding. 
Mice were kept under specified pathogen free (SPF) conditions 
in individual ventilation cages (IVC) in the animal house of the 
Department of Immunology, Eötvös Loránd University, Budapest, 
Hungary. Treatments of mice in this study were carried out in 
strict accordance with the recommendations in the Guide of 
the Institutional Animal Care and Ethics Committee at Eötvös 
Loránd University that operated in accordance with permissions 
22.1/828/003/2007 and XIV-I-001/517-4/2012 issued by the Food 
Chain Safety and Animal Health Directorate of the Government 
Office of Pest County, Hungary.
immunohistochemical localization of the  
Bovine and Mouse Fcrn in the spleen
Ten-week-old female bFcRn transgenic and wt BALB/c mice 
were immunized intraperitoneally (i.p.) with 50  μg keyhole 
limpet hemocyanin (KLH; Sigma-Aldrich) conjugated to TNP in 
complete Freund adjuvant (CFA), boosted 3 weeks later with 25 μg 
TNP-KLH in incomplete Freund adjuvant (IFA), and euthanized 
3  days thereafter. Spleens of non-immunized and immunized 
mice were frozen in liquid N2, embedded in Killik cryostat 
embedding medium (Bio-Optica, Milano, Italy), and 10–15 μm 
sections were made and fixed with acetone. Before staining, sec-
tions were blocked by 5% BSA for 20 min at RT. Cell populations 
were identified with Alexa Fluor 568-labeled anti-Thy-1 (clone 
IBL-1), Cy3-labeled anti-MARCO (clone IBL-12), and MOMA 
(sialoadhesin/CD169, clone IBL-13) mAbs, that were developed in 
our laboratory (22–24). Anti-B220 (clone RA3-6B2), F4/80, Gr-1/
Ly-6C/G (clone RB6-8C5), MAdCAM-1 (clone MECA-367) were 
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obtained from the American Type Culture Collection, Rockville, 
MD, USA. FITC-labeled and PE-conjugated goat anti-rat Igs were 
purchased from BD Pharmingen (San Diego, CA, USA). Dendritic 
cells were identified using hamster mAb against mouse CD11c 
(clone N418). Bovine FcRn-expressing cells were identified by 
Alexa Fluor 488- or Alexa Fluor 647-conjugated anti-bFcRn mAb 
(Z15_6D5/8) that was developed in our laboratory (19), while 
mFcRn expressing cells were stained by Armenian hamster anti-
mFcRn serum provided by Dr. S. Akilesh (Washington University, 
St. Louis, MO, USA) (14) and FITC-labeled anti-hamster rabbit 
IgG (Southern Biotechnology Associates Inc., Birmingham, AL, 
USA). The pictures of fluorescence staining were edited with 
Adobe Photoshop, using adjustments for black level and hue for 
the entire images.
Ex Vivo antigen Presentation assay
Ten-week-old female bFcRn transgenic and wt BALB/c mice were 
immunized i.p. with 100 μg OVA in CFA. Mice were boosted i.p. 
with 50 μg OVA in IFA on day 14, and sacrificed on day 21. Single-
cell suspension was prepared from the spleen of the mice in RPMI 
medium containing 10% FCS (Sigma-Aldrich). To analyze the 
number of Ag-specific T helper cells after immunization, we used 
BD Mouse IL-2 ELISPOT Set (BD Biosciences, NJ, USA) accord-
ing to the manufacturer’s instructions with slight modifications. 
Ninety-six-well ELISPOT plates were coated with 5 μg/ml purified 
anti-mouse IL-2 antibody in 100 μl PBS and incubated at RT for 
2 h. Plates were washed with PBS and blocked with RPMI + 10% 
FCS for 1 h at RT. Spleen cells were plated in concentrations of 
1 × 106 and 5 × 105 cells per well in 200 μl of RPMI + 10% FCS. Cells 
were pulsed with OVA or KLH at 10 and 50 μg/ml final concentra-
tion, which was determined in pilot experiments. For negative 
control, splenocytes were plated without Ag-restimulation. Plates 
were incubated for 22 h at 37°C in 5% CO2 atmosphere then washed 
thoroughly with PBS-Tween (0.05%), and biotinylated goat anti-
mouse IL-2 antibody was added at 2 μg/ml concentration in 100 μl 
PBS-Tween and incubated for 2 h at room temperature. After wash-
ing, streptavidin-HRP conjugate was added in 100 μl PBS-Tween. 
After 1 h incubation at RT, plates were washed five times with 
PBS-Tween and then five times with PBS. The plates were then 
incubated with 3-amino-9-ethylcarbazole (AEC, Sigma-Aldrich), 
and H2O2 at room temperature in 0.1M acetate buffer, pH 5.2, and 
the reaction was terminated by a wash with distilled water. The 
spots were counted in the ImmunoScan ELISPOT reader (Cellular 
Technology) and evaluated by ImmunoSpot software version 3.2 
(Cellular Technology).
Flow cytometry
Single-cell suspensions from spleens were made and 1  ×  106 
isolated cells were stained with fluorochrome-conjugated specific 
antibodies at 4°C for 50 min in staining buffer (PBS with 0.1% BSA 
and 0.1% sodium azide), washed twice, and then analyzed using a 
FACSCalibur equipped with CellQuest software (BD Biosciences, 
San Jose, CA, USA). Anti-mouse CD45R/B220-PECy5 or CD45R/
B220-PerCP-Cy5.5, CD19-FITC, CD3-PE, CD11b-PerCP-Cy5.5 
were obtained from eBioscience (San Diego, CA, USA). Anti-mouse 
CD4-PE, CD11c-PE, Gr-1 (Ly-6G)-PE were purchased from BD 
Pharmingen (San Diego, CA, USA) and anti-mouse F4/80-Alexa 
Fluor 647 is from Caltag Laboratories (Buckingham, UK). Isotype 
controls were obtained from BD Pharmingen or eBioscience.
For intracellular staining, cells were incubated with fluoro-
chrome-conjugated antibodies specific for cell surface molecules, 
as described previously, then washed twice, and fixed by adding 
4% formaldehyde for 10  min at 4°C. Subsequently, fixed cells 
were treated with 0.2% saponin (Sigma-Aldrich) and 0.1% BSA 
(Sigma-Aldrich) containing PBS for 10 min, washed, and stained 
with Alexa Fluor 488- or Alexa Fluor 647-conjugated anti-bFcRn 
mAb (Z15_6D5/8) in the same saponin-containing buffer for 1 h 
at 4°C. After staining, cells were washed twice and all samples 
were resuspended in staining buffer and analyzed by FACS Aria 
III equipped with FACSDiva software (BD Biosciences, San Jose, 
CA, USA). Data were evaluated with FlowJo software (FlowJo LLC, 
Ashland, OR, USA).
lectin-immunohistochemical analysis of  
the number, size, and Kinetics of 
spleen germinal centers
Ten-week-old female bFcRn transgenic and wt BALB/c mice were 
immunized i.p. with 50 μg TNP-KLH in CFA, boosted 3 weeks later 
with 25 μg TNP-KLH in IFA, and were analyzed on days 24, 28, and 
42 of the immune response (3 Tg and wt mice in each group). Two 
independent sections were made for each spleen specimen (S1 and 
S2, distance at least 500 μm) for two-dimensional cross-sectional 
evaluation of GCs. Sections were mounted onto ready-to-use 
microscope slides (Menzel, Thermo Scientific, MA, USA), were 
air-dried overnight, fixed in cold acetone for 5  min, air-dried 
again, and stored at −80°C until analysis. Anti-mouse IgD (BD 
Pharmingen, Franklin Lakes, NJ, USA) and biotinylated peanut 
agglutinin (PNA; Sigma-Aldrich) were used to analyze GC in the 
spleen. Developing rat anti-mouse IgD and PNA double labeling 
was done either by using enzymatic detection in conjunction with 
anti-rat IgG-HRPO conjugate (using H2O2 and AEC substrate) and 
extravidin-AP (developed with NBT-BCIP substrate combination) 
or fluorescent detection using PromoFluor350 labeled streptavidin 
(PromoKine, Germany) and anti-rat IgG-FITC (BD Pharmingen). 
Digital images of GCs, as identified by PNA within IgD positive 
mantle zone, were acquired on an Olympus BX61 microscope using 
a 10× objective and the analySIS software (Olympus, Germany). 
GC boundaries were manually assigned to each GC, and area was 
determined using analySIS software.
immune response against low amount of ag
Trinitrophenyl-KLH was used for immunization, and TNP-BSA 
was used as a test Ag for determining anti-hapten antibody level, 
as published earlier (9). The number of incorporated TNP resi-
dues per KLH molecule was 400 and per BSA molecule was 24. 
Animals were i.p. immunized with different amount of TNP-KLH 
in CFA and challenged 21 and 42 days later with TNP-KLH in 
IFA according to Table  1. High-binding ELISA plates (Costar 
9018, Corning, NY, USA) were coated with TNP-BSA (4 μg/ml); 
in 0.1M sodium carbonate–bicarbonate buffer (pH 9.6) for 2 h at 
room temperature and then were washed with 0.1M PBS (pH 7.2) 
containing 0.05% Tween 20 (PBS-Tween) and blocked with PBS 
containing 1% BSA for 1 h at room temperature. Serially diluted 
serum samples were added to the wells and incubated for 1 h at 
July 2015 | Volume 6 | Article 3574
Schneider et al. bFcRn overexpression augments immune response
Frontiers in Immunology | www.frontiersin.org
room temperature. Each plate included standard controls of serially 
diluted Ag-specific immune sera. After washing, bound serum IgG 
was detected by HRP-labeled goat anti-mouse IgG (1:4000-fold 
dilution, Southern Biotechnology Associates, Birmingham, AL, 
USA). The peroxidase-conjugated antibodies were detected using 
tetramethylbenzidine (TMB, Sigma-Aldrich) as the chromogen 
and hydrogen peroxide as the substrate, and OD at 450 nm was 
measured with the Multiscan ELISA Plate Reader (Thermo EC). 
Ag-specific IgG titers as half-maximal values were determined 
by GraphPad Prism 5 non-linear regression to the hyperbolic 
saturation function.
statistical analysis
Statistical differences were assessed by Student’s two-tailed t test 
and two-way ANOVA. Values were considered significant and were 
indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001.
results
bFcrn is expressed in the spleen  
and lymph node
Transgenic mice that overexpress the bFcRn carry five copies of a 
bovine genomic fragment, encoding the bFcRn α-chain (FCGRT) 
(6). Upon immunization, these animals launch an enhanced 
antibody response against a variety of T-dependent antigens with 
mechanisms, which have not been completely elucidated yet. To 
test whether the expression of transgene containing all regula-
tory elements of the bFcRn gene or its chromosomal integration 
influences the architecture of spleen, we compared the structure 
of the wt and Tg spleen using tissue immunofluorescence for 
lymphoid compartmentalization and the expression pattern 
of endogenous mFcRn and transgenic bFcRn, respectively. We 
found that the spleen of Tg mice showed normal T-, B cell, and 
marginal zone (MZ) compartmentalization indistinguishable 
from wt controls using Thy-1, B220, Gr1, or MadCAM-1-specific 
labeling (Figure 1). Similar results were obtained with animals 
immunized with TNP-KLH (data not shown). Next, we correlated 
the cell-type-specific expression of bFcRn to the mFcRn in the 
spleen and lymph nodes. mFcRn localization was performed 
by using a mFcRn-specific hamster antiserum that had been 
developed and validated previously (14); as negative control, we 
used non-specific hamster serum with the same secondary reagent 
and found no specific staining. For bFcRn detection, we used the 
TaBle 1 | immunization protocols for testing the immune response to 
low-dose TnP-Klh.
cohorts (5 BALB/c – 5 
bFcRn Tg BALB/c)
immunization day TnP-Klh (μg/
animal) i.p.
adjuvant
1 0 100 CFA
21 50 IFA
42 50 IFA
2 0 10 CFA
21 5 IFA
42 5 IFA
3 0 0.5 CFA
21 0.5 IFA
42 0.5 IFA
bFcRn-specific mAb (Z15_6D5/8) that we recently developed and 
showed that it does not cross-react with the endogenous mFcRn 
(19) (Figures 2A–D). Staining of F4/80-positive red pulp MΦs 
revealed an expression pattern of bFcRn in Tg mice, which is 
similar to the mFcRn patterns in wt mice (Figures 2E–H) and 
supporting previous studies that indicated mFcRn expression in 
these cells (14). However, while mFcRn is clearly restricted to 
red pulp MΦs, bFcRn is, in addition, also strongly expressed in 
the MZ (Figure 3). This MZ display prompted us to perform a 
more detailed analysis of this compartment. Murine MZ harbors 
two distinct types of MZ MΦs, of which the metallophilic MΦs 
within the inner ring are identified by their Sn/CD169 expression, 
whereas the MZ MΦs located in the outer ring display MΦ receptor 
with collagenous structure (MARCO) (25). We found that both 
macrophage subsets display bFcRn in Tg mice. In contrast, no 
similar expression of mFcRn was detectable in either of these cell 
types (Figure 3). In peripheral lymph nodes, we observed both 
mFcRn and bFcRn staining in macrophage-like cells in the interfol-
licular areas of the lymph node cortex. In addition, we detected 
bFcRn expression in the CD169-positive, subcapsular sinus (SCS) 
MΦ, whereas mFcRn was not detected in these cells (Figure 4). 
These expressional patterns did not change after immunization 
(data not shown) and largely corroborate the previously reported 
analysis of the mFcRn expression in the spleen and lymph node 
(14) with the exception that we did not detect mFcRn in the MZ 
MΦ in the spleen or in SCS MΦ in lymph nodes of wt animals. 
These differences in staining pattern may perhaps be attributed 
to different protocols or reagents.
We could detect bFcRn expression in CD11c+ DCs within the 
T cell zone, the periarteriolar lymphoid sheath of the white pulp 
(Figure  5), and this expressional pattern did not change after 
immunization (data not shown). We could also see bFcRn positivity 
in the B cell zone of the spleen of bFcRn Tg mice (Figures 2B,F and 
3B,F). Since DCs and B cells have crucial roles in the T-dependent 
immune response, the findings that they express bFcRn prompted 
us to confirm these data with flow cytometric analysis.
We isolated splenocytes from non-immunized mice and found 
that most of the F4/80+ MΦ (Figures  6A,B), CD11b+/CD11c+ 
DCs (Figures 6C,D), CD19+/B220+ B cells (Figures 6E,F), but not 
the Gr1+/CD11b+ splenic neutrophil granulocytes (Figures 6G,H) 
express bFcRn corroborating our immunohistochemical observa-
tions. bFcRn expression in MΦs was analyzed with a differently 
conjugated antibody as compared with the one that we used for 
DCs, B cells, and granulocytes. Thus, although we could not 
compare the bFcRn expression in the MΦs to the other cell types, 
our data suggest that the bFcRn expression in B cells is lower 
than its expression in DCs. The expression of bFcRn in DCs is 
another indication that the bFcRn promoter ensures appropriate 
cell-specific expression as the endogenous mFcRn expression has 
been detected in these APCs earlier (15–17). It also corroborates 
our previous result that demonstrated bFcRn expression in bone 
marrow-derived DCs from the Tg mice using Western blot and 
Q-PCR analyses (13). On the other hand, the same study did not 
show bFcRn expression in Tg splenic B cells, in Western blot 
analysis using a different antibody, which is perhaps less specific 
for the bFcRn (13). Nevertheless, earlier studies demonstrated 
mFcRn expression in mouse primary B cells (17, 18) and that 
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has been also indicated in gene expression analysis in immune 
cells (26). Therefore, bFcRn expression in splenic B cells does not 
reflect ectopic expression of this transgene in the bFcRn Tg mice.
Overexpression of bFcrn Further increases the 
Frequency of ag-specific, activated T helper 
cells in the spleen after immunization
We previously demonstrated that Ag–IgG IC loaded, bFcRn-over-
expressing bone marrow-derived dendritic cells improve antigen 
presentation significantly as measured by the in vitro proliferation 
of Ag-specific CD4+ T cells (13). In order to confirm that bFcRn 
overexpression leads to increased number of activated Ag-specific 
helper T cells in vivo in the secondary lymphoid organ, we intra-
peritoneally immunized Tg and wt mice with OVA. This priming 
was followed by a booster after 14 days, and 7 days later, we isolated 
splenocytes, reactivated them ex vivo with the same Ag (OVA) or 
with an unrelated Ag (KLH). The number of activated Ag-specific 
CD4+ T cells were determined by IL-2 ELISPOT assay, following 
previously published protocols (27, 28). Size of the spleens, total 
numbers of splenocytes, and the ratios and absolute numbers of 
CD4+ T cells, neutrophil granulocytes, DCs, MΦ, B-, and T cells 
were also compared between non-immunized and immunized 
Tg and wt mice. In non-immunized mice, we did not observe 
difference in the ratios of T- and B cells, CD4+ T cells, neutrophil 
granulocytes, DCs, and MΦs (Figure 7), or in the spleen size and 
number of splenocytes (data not shown) between Tg and wt mice, 
confirming our previous observation (9).
Immunization resulted in an augmented humoral immune 
response of the bFcRn Tg mice that was reflected by sig-
nificantly higher OVA-specific IgG titers, larger spleens and 
increased number of splenocytes on day 21 as compared with 
their wt controls (Figures 8A,B). We observed significantly 
higher ratio of T lymphocytes (CD3+), helper T (CD4+) 
lymphocytes in wt mice than that of Tg mice, while ratios 
of neutrophil granulocytes (Gr1+/CD11b+), DCs (CD11b+/
CD11c+) and MΦs (F4/80+) were significantly higher in the 
spleen of Tg mice than those of wt mice (Figures 8C,D). We 
also calculated the total numbers of these cell populations 
based on the total number of splenocytes and their ratios, 
and observed significantly more B cells, T helper cells, neu-
trophil granulocytes, DCs and MΦs in the spleen of Tg mice 
(Figure 8E), reflecting to our previous observations (9, 13). 
Although Tg spleen contained slightly higher total numbers of 
CD3+ T lymphocytes, this difference was not significant. We 
also noted that T helper cells represented app. 85 or 70% of the 
total T cells in the Tg and wt spleen, respectively, suggesting 
increased activation and proliferation of this cell population 
in Tg mice (Figure 8E).
FigUre 1 | histological analysis of the spleen of bFcrn Tg mice. White 
pulp in spleens in wt (a,c) and Tg mice (B,D) contains clearly defined T cells 
(Thy-1/CD90, green) and B cells (B220, red) forming separate compartments. 
The white pulp is encircled with MAdCAM-1 positive (red) marginal sinus, 
separating the white pulp from the red pulp containing Gr1-positive (green) 
myeloid cells (representative examples for a cohort n > 6; scale bar: 100 μm).
FigUre 2 | expression of Fcrn and bFcrn in wt and bFcrn Tg mice in 
the red pulp. mFcRn in wt mice was stained with anti-mFcRn or control 
hamster serum or anti-bFcRn mAb as indicated (a,c,D). bFcRn in Tg samples 
(B) was reacted with mouse anti-bFcRn mAb conjugated to Alexa Fluor 488. 
Note the accentuated reactivity of bFcRn in the marginal zone region [(B), 
arrow]. (e,F) illustrate co-expression of mFcRn and bFcRn with F4/80, with the 
insets (g,h) corresponding to the rectangles delineated with dotted line in (e,F) 
Arrows point to double-positive cells, arrowheads indicate FcRn-receptors only 
positive cells in (g,h) (representative examples for a cohort n > 6, bar size: 
100 μm).
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Then, we analyzed the number of IL-2 producer T helper 
cells in unseparated 1 ×  106 and 5 ×  105 splenocytes from 
non-immunized and OVA immunized mice. When we counted 
the IL-2 spots in the ELISPOT wells, we did not observe IL-2 
positivity in cases of non-immunized (NI) mice, and found 
only a few spots when the mice were immunized with OVA 
FigUre 3 | Display of bFcrn by MZ macrophage subsets in Tg 
mice. Co-labeling of spleen sections from wt mice for mFcRn (a,c,e,g) or 
from Tg mice for bFcRn (B,D,F,h) for sialoadhesin/CD169 (a–D) or 
MARCO (e–h) shows the lack of mFcRn expression in MZ, whereas in Tg 
mice, bFcRn is co-expressed by both MZ macrophage subsets. Arrows 
point to double-positive cells, arrowheads indicate FcRn-receptors only 
positive cells (representative examples for a cohort n > 6, bar size: 
100 μm).
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but the splenocytes were not reactivated with this Ag. We 
detected more IL-2 spots when mice were immunized with 
OVA, and their splenocytes were reactivated with another Ag 
(KLH). Finally, the highest number of spots appeared when 
mice were immunized with OVA, and their splenocytes were 
reactivated with the same Ag (Figure  8F). (We got similar 
FigUre 4 | expression of Fcrn in peripheral lymph nodes. mFcRn in wt 
lymph nodes (a,c,e) and bFcRn in Tg lymph nodes (B,D,F) show slightly different 
tissue distribution, where wt mice express mFcRn (green) only in the interfollicular 
region, whereas in Tg mice, substantial co-expression of bFcRn (green) is seen 
with the Sn/CD169+ subcapsular metallophilic MΦs (red, overlap seen as yellow, 
indicated with an arrow pointing at a group of double-positive cells in (F)]. The 
high power insets (e,F) correspond to the dotted rectangular area in the merged 
pictures scale (representative examples for a cohort n > 6, bar size: 100 μm).
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trends with fewer spots when 5 × 105 splenocytes were used; 
data not shown.) Although these data did not show significant 
difference between Tg and wt mice, they reflected augmented 
T helper cell activation in Tg mice as there were significantly 
fewer T helper cells in the wells of Tg mice compared to their 
controls (Figure 8C). In addition, immunization of Tg mice 
resulted in larger spleen and more splenocytes and calculat-
ing all these factors clearly indicated that the spleen of the 
immunized Tg mice contained approximately threefold more 
activated, Ag-specific T helper cells as compared to their 
wt controls (Figure 8G). These data validated our previous 
in vitro antigen presentation assay using bone marrow-derived 
DCs (13).
Overexpression of bFcrn expands the number 
and size of germinal centers
To determine whether increased number of Ag-specific helper T cells 
in bFcRn Tg mice can be correlated with GC formation, GCs were 
assessed by quantitative, cross-sectional analysis in spleens of TNP-
KLH-challenged Tg and wt mice during the secondary immune 
response at different time points after the booster immunization in 
which we observed significant difference in the humoral immune 
response comparing the bFcRn Tg mice and their wt controls (29).
Similarly to the OVA immunization experiment, we found 
that TNP-KLH immunization resulted in larger spleen and 
higher Ag-specific IgG titers in the Tg mice as compared with 
their controls (data not shown). Cross-sectional GC size in spleens 
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were evaluated by quantitative analysis at different time points after 
booster immunization as we focused on the secondary immune 
response and analyzed the GCs after the booster immunization 
(day 21). We evaluated 606 GCs in total of 36 sections prepared 
on days 24, 28, and 42 of immunization from three Tg and wt 
mice at each time point (Table 2). Ag-specific B cells within GCs 
were identified by PNA staining, while surrounding non-GC B 
cells were counterstained by their IgD positivity (Figure 9A). GCs 
varied widely in size from a minimum of 2299 μm2 to a maximum 
of 113,986 μm2 in case of the wt animals, or from a minimum of 
3427 μm2 to a maximum of 173,799 μm2 in case of the Tg mice 
with a wider range of distribution in the Tg mice. These data gave 
the median values of 14,431 μm2 for wt and 26616 μm2 for Tg on 
day 24, 15,122 μm2 for wt and 29,655 μm2 for Tg mice on day 
28, and 14,972 μm2 for wt and 30,263 μm2 for Tg mice on day 
42 indicating that the average size of the GCs is approximately 
twofold in the bFcRn Tg mice. Distribution of GC sizes were 
non-normal, right-skewed, indicating that most of the GCs were 
small and medium sizes but some of them were extremely large, 
especially in the Tg spleens (Figure 9B). GC density [number of 
GCs in area units (square millimeter) of spleen sections] did not 
differ between wt and Tg groups, in both cases it increased radically 
after the booster immunization (day 21), peaked on day 28, and 
then gradually reduced (Figure 9C). From day 28 of immunization, 
we observed larger average ratio of the GC size per section area 
(Figure 9D), many more GCs (Figure 9E), and much larger total 
GC area (Figure 9F) in Tg spleen comparing with those of wt.
FigUre 5 | expression of bFcrn in splenic dendritic cells in  
the T cell zone of bFcrn Tg mice. DCs expressing CD11c (green) 
within the white pulp [arrowhead in (a)] show similar level of bFcRn 
expression as red pulp MΦs but less intense display of bFcRn  
[single arrow in (B)] compared to marginal zone expression [double arrows 
in (B)], the rectangle delineated by dotted line in inset (c) corresponds  
to (D) (representative examples for a cohort n > 6, bar size:  
100 μm).
Tg Mice Demonstrated efficient immune 
response even to Very low Dose of ag
We also wanted to test whether overexpression of bFcRn has an 
impact on the dose-dependency of the immune response in vivo. 
Therefore, we immunized bFcRn Tg and wt mice with different 
amounts of TNP-KLH in three cohorts, based on the immuniza-
tion protocols summarized in Table 1. As readout, we analyzed the 
TNP-specific serum titers. As expected from our previous studies, 
Tg mice produced four- to sixfold higher TNP-specific titers with 
even higher maximum titers, wider titer range as compared with 
their wt controls. Surprisingly, even the medium antigen dose 
used for cohort #2 (10/5/5 μg/mouse) has led only in Tg mice 
already to an optimal TNP-specific humoral immune response, 
as immunization with higher antigen doses (cohort #1) did not 
result in significantly higher titers. In contrast, in wt mice, even 
the highest antigen doses did not result in titers equivalent to those 
of Tg mice. Even more important is the finding that Tg mice are 
very responsive to tiny amounts of antigen as the Ag doses used in 
cohort #3 (0.5/0.5/0.5 μg/mouse) triggered a significant humoral 
immune response (Figure 10).
Discussion
In this study, our objective was to gain further insights into the 
augmented humoral immune response of the bFcRn Tg mice, 
which we observed using T-dependent Ags (8, 9, 12, 13). First, we 
analyzed the microarchitecture of the bFcRn Tg spleen and found 
FigUre 6 | Flow cytometric analysis of bFcrn expression on 
splenocyte subsets. Splenocytes were stained with antibodies recognizing 
Gr-1, CD11b, CD11c, F4/80, CD19, and B220 markers. For intracellular 
labeling of bFcRn Alexa Fluor 488 (MΦs) or Alexa Fluor 647 (DCs, B cells, 
granulocytes), conjugated Z15_6D5/8 mAb were used. Each cell types were 
gated based on their cell-specific markers (a,c,e,g) and their bFcRn 
expression was presented in related histograms (B,D,F,h). IC, isotype control, 
6D5/8: Z15_6D5/8.
FigUre 7 | Flow cytometric analysis of the spleen cell type distribution in 
non-immunized bFcrn Tg and wt mice. Splenocytes from non-immunized wt 
and bFcRn Tg mice (five in both groups) were stained using the following 
markers: B220, CD3, and CD4 for B-, T-, and helper T cells, respectively, Gr1 and 
CD11b for neutrophil granulocytes, CD11b and CD11c for dendritic cells, and 
F4/80 for macrophages. Values on the dot plot panels shown are the mean ± SD.
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normal T-, B cell, and MZ compartmentalization indistinguishable 
from wt controls (Figure 1). Then, we compared the transgenic 
bFcRn expression to the endogenous mFcRn expression in the 
spleen and lymph node. Our mFcRn expression analysis in these 
secondary lymphoid organs largely corroborated with previous 
observation (14) with the exception that we could not detect mFcRn 
expression in the MZ MΦs in the spleen or in the SCS MΦs in the 
lymph node. On the other hand, we detected bFcRn expression in 
the outer and inner rings of the MZ, representing the MARCO+ 
MZ MΦs and the CD169+ marginal metallophilic MΦs, in addition 
FigUre 8 | comparison of the spleen cell type distribution and the 
number of il-2 producer helper T cells in immunized wt and bFcrn Tg 
mice. bFcRn Tg and wt mice (five in both groups) were immunized with OVA on 
days 0 and 14. Mice were sacrificed on day 21 and their immune response were 
compared by evaluating their OVA-specific IgG titers on day 21 (a), spleen 
weight and spleen cell numbers (B), distribution of spleen cell types using the 
following markers: B220, CD3, and CD4 for B-, T-, and helper T cells, 
respectively, Gr1 and CD11b for neutrophil granulocytes, CD11b and CD11c for 
dendritic cells, and F4/80 for MΦs (c–D). Total number of spleen cell types was 
calculated based on the total number of splenocytes and the ratio of the 
analyzed cell populations (e). IL-2 producer T helper cells of unseparated 
splenocytes (1 × 106 cells/well) were also analyzed using 10 or 50 μg/ml OVA or 
non-specific antigen (KLH) for recall activation. As negative controls, splenocytes 
from non-immunized (NI) mice were stimulated with OVA, or splenocytes from 
OVA immunized mice were incubated without reactivating them with OVA, or 
splenocytes from OVA immunized mice were incubated with unrelated antigen 
(KLH). Data points represent the average spot numbers/ELISPOT wells (F). Total 
numbers of IL-2 producer helper T cells were calculated based on the total 
number of CD4+ helper T cells in wt and Tg spleen (g). Data on dot plot panels 
and graphs show the mean ± SD (*P < 0.05; **P < 0.01).
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TaBle 2 | survey of cross-sectional gc size evaluation (number of gcs analyzed).
no. of evaluated gcs
Daya wt1b wt2b wt3b Tg1b Tg2b Tg3b
s1 s2 s1 s2 s1 s2 s1 s2 s1 s2 s1 s2 wt Σc Tg Σc
24 26 17 1 12 13 19 4 10 11 20 6 10 88 61
28 14 12 28 20 20 30 23 38 29 38 10 16 124 154
42 19 12 5 13 4 16 11 17 16 37 9 20 69 110
281 325
a wt and Tg mice were immunized on days 0 and 21, and their spleen was analyzed at the indicated time points.
bNumber of GCs evaluated per two independent spleen sections per mice (S1 and S2, distance at least 500 μm). Three wt and three Tg mice were analyzed at each time point.
cTotal number of GCs evaluated per time point in wt or Tg group.
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to the mFcRn-positive components in the red pulp. Importantly, 
these findings indicate that the lineage-specific regulation of bFcRn 
expression is similar to its murine ortholog, although Tg bFcRn has 
a stronger expression in the MZ MΦs compared with red pulp MΦs 
(Figures 2–4). This enhanced expression of bFcRn by MZ MΦs 
in spleen and SCS MΦs in peripheral lymph nodes may provide 
augmented stimulation for the humoral immune response. It was 
previously shown that MΦs of the splenic MZ are dispensable 
for T cell activation (30); however, a recent study demonstrated 
their necessity for progression of T-dependent B cell responses 
and formation of GCs, in a fashion analogous to lymph node MΦs 
(31). Indeed, the position and phenotype of CD169+ marginal 
metallophilic MΦs resemble to that of MΦs lying just underneath 
the SCS of lymph nodes (32). SCS MΦs were shown to be involved 
in Ag–IgG IC translocation on the surface of these MΦs from 
their protrusions into the sinus to areas of the MΦs in contact 
with follicular B cells. At the interface between these MΦs and 
follicular B cells, there is accumulation of native Ag or ICs leading 
to cognate B cell activation. Alternatively, in case of non-cognate 
B cells, ICs bind to the complement receptor on B cells and then 
transported into the follicle, facilitating deposition of these ICs 
on the follicular dendritic cells (FDCs) (33–35). More recently, 
it was demonstrated that these SCS MΦs are poorly endocytic, 
have low degradative capacity, and retain ICs on the cell surface. 
Such function is considered as a specialized antigen-presenting 
cell function, and that these ICs contribute to GC formation and 
affinity maturation (36). Yet, these authors did not exclude the 
possibility that ICs are transported inside these cells in a specialized 
form of transcytosis. Based on our data that demonstrates strong 
bFcRn expression in marginal metallophilic MΦs in the spleen or 
SCS MΦs in lymph nodes, it is tempting to hypothesize that the 
bFcRn expression in these cells may contribute to IC protection 
and transportation leading to increased B cell activation, coupled 
with more efficient GC formation and affinity maturation. Further 
analyses tracing the transport of detectable antigen in immune 
complex form may provide further understanding in this immune 
complex transport pathway. The role of MARCO+ MZ MΦs in 
capturing ICs and stimulating B cells, including MZ B cells is 
less characterized, but we cannot exclude the possibility that this 
process is also mediated by FcRn. Further studies are warranted 
to carefully analyze the expression of mFcRn and hFcRn in these 
cells and to validate this hypothesis.
In parallel with follicular B cell stimulation, the activation of T 
helper cells by professional APCs represents the other arm of the 
T-dependent humoral immune response. After the initial contact 
with antigen, B cells travel to the border between the T cell zone 
and B cell follicle where they interact with cognate T cells to form 
Ag-specific cell clusters. Thus, activated T helper cells are crucially 
important in stimulating cognate B cells and consequently strongly 
influence Ag-driven B cell activation and then their maturation 
within the GCs after some of these activated cognate T helper cells 
become follicular T helper (TFH) cells. FcRn plays major roles in 
antigen presentation of Ag–IgG IC by professional APCs and in 
generating Ag-specific antibodies (15, 17, 37–39). This process is 
initiated at the cell surface of most professional APCs, as Ag-IgG 
IC binds to the FcγRs which triggers both the internalization of 
this IC and its delivery into endocytic vesicles. While FcRn recycles 
monomeric IgG from these compartments onto the cell surface, 
it directs the uptaken Ag-IgG IC into vesicles where processing 
of the complexed antigen releases epitopes that are loaded onto 
MHC class I (MHC-I) and class II (MHC-II) molecules that 
subsequently stimulate the activation of cognate CD8+ and CD4+ 
T cells, as has recently been reviewed (5).
We have previously demonstrated that bone marrow-derived 
dendritic cells isolated from the bFcRn Tg mice stimulate CD4+ 
T cell proliferation much more efficiently when loaded with 
Ag-IgG ICs than those of wt controls (13). Our current findings 
that splenic DCs of Tg mice express bFcRn (Figures 5 and 6) 
supports that previous observation and suggests that these cells 
have an augmented APC activity in the spleen on the course 
of the immune response. This assumption was confirmed by 
showing that immunization results in threefold more activated, 
Ag-specific helper T-cells in the Tg spleen than that of wt controls 
(Figure 8). Immunization resulted not only more helper T cells 
in the Tg spleen but substantial differences in cell populations 
(Figure  8), although there were no such differences between 
non-immunized Tg and wt mice (Figure  7) supporting our 
previous observations (9, 12).
This remarkable difference in the splenic T helper cell activity 
of the Tg mice urged us to analyze the size distributions and 
kinetics of the formation of GCs in the spleen during the second-
ary immune response. We observed that most of the GCs were 
small and medium sizes in the wt spleen (Figure 9) similarly 
as described before (40). In the case of Tg mice though, while 
there were many small or medium sized GCs in the TG spleen, 
many of them were much larger than the controls and thus Tg 
GCs were averagely twice as large as that of the controls on days 
28 and 42 of the immunization. Although, we found similar GC 
FigUre 9 | analysis and comparison of germinal centers (gc) of 
TnP-Klh immunized wt and bFcrn Tg mice after booster 
immunization on day 21. bFcRn Tg and wt mice were immunized with 
KLH-TNP, boosted 3 weeks later and GCs were analyzed on day 24, 28, 
and 42 of the immune response (3 Tg and wt mice in each group). (a) 
Well-established GCs were identified with their IgD (naïve B cells in red) 
and PNA (GC B cells in blue) positivity (representative examples for a 
cohort n > 6; scale bar: 100 μm). (B) Each dot represents an individual 
GC and the average size of the GCs is approximately twofold in the bFcRn 
Tg mice. Lines of the scatter dot plot indicates means with SDs; the high 
SD values indicate a non-normal, right-skewed distribution of GC sizes, as 
the result of a small frequency of very large GCs density of GCs in the 
spleens [number of GCs in area units (square millimeter) of spleen 
sections] (c), average ratio of the GC size per section area (D), relative 
number of GCs (e), and total GC area (F) in the spleens were evaluated. 
Inserts (e,F) represents data relative to the average wt data on day 24 of 
immunization. Data show the mean ± SD (*P < 0.05; **P < 0.01; 
***P < 0.001).
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FigUre 10 | comparison of the ag-specific igg titer in wt and bFcrn 
Tg mice when low amount of ag was used for immunization. Three 
cohorts of Tg and wt mice were i.p. immunized with different amount of 
TNP-KLH (see also Table 1) and their TNP-specific IgG titers were measured 
by ELISA. Data show the mean ± SD (*P < 0.05; **P < 0.01).
density both in wt and Tg spleen, based on the larger spleen in 
Tg mice the total number of GCs were almost doubled in the 
Tg mice than that of wt controls (Figure 9). These observations 
confirmed our previous studies that showed many more antigen-
specific B cells in the bFcRn Tg mice than their wt controls (8, 9).
The much larger size of the Tg GCs could be the result of the 
many more activated T helper cells, and we cannot exclude the pos-
sibility that the strong bFcRn expression in the MZ MΦs contribute 
to this outcome, too, resulting in more cognate B cell activation, 
and more Ag-IgG ICs into the GCs (as discussed earlier).
Furthermore, our data show that primary splenic B cells from 
the Tg mice express bFcRn, too, although at lower expressional 
level than DCs (Figures 2 and 6). This new finding corroborate to 
previous studies that demonstrated mFcRn expression in mouse 
splenic B cells (17, 18), although other studies failed to show 
FcRn expression in primary B cells or B cell lines (38, 41, 42). The 
expression of mFcRn in splenic B cells has been also indicated 
by the Immunological Genome Project database (26), and thus 
these studies support our hypothesis that the B cell specificity 
of the transgenic bFcRn expression reflects to the endogenous 
mFcRn, too. The role of FcRn in B cell has been hypothesized 
to regulate IgG (and albumin) catabolism and involve in APC 
function of the B cells (17, 18). The potential role of FcRn in B cell 
APC function is an exciting hypothesis as activated B cells present 
antigens to cognate helper T cells in the initial phase of the immune 
response and later to cognate TFH cells during GC center reaction. 
Particularly in the GC reaction, B cells recognizing Ag–IgG ICs 
presented by FDCs receive simultaneous activating signals from 
their B cell receptor (BCR) and inhibitory signals via cross-linking 
of the inhibitory FcγRIIB, which thereby sets a threshold for B cell 
activation (43). As a consequence, B cells that lose their affinity for 
the presented Ag will only receive signals through the inhibitory 
FcγRIIB, which could result in apoptosis, while B cells carrying a 
BCR with sufficiently high affinity will become fully activated and 
proceed further to antibody production (43). Via this route, these 
activated GC B cells uptake Ag–IgG IC via robust BCR-mediated 
Ag capture from FDCs (and thus differently compared to, e.g., 
DCs, which internalize all kinds of Ag–IgG ICs via their classical 
Fcγ receptors) and present the processed Ag on MHC complexes 
to TFH cells. Higher BCR affinity is directly associated with greater 
Ag capture and uptake leading to a higher density of peptide–MHC 
presentation on the surface of the B cell. As a consequence, these B 
cells have stronger interaction with the TFH cells, which then results 
in greater magnitude of T cell help for re-entry into the dark zone 
where these B cells undergo somatic hypermutation and can collect 
more affinity-enhancing mutations (44). From the perspective of 
our study, we hypothesize that FcRn may also be involved in this 
APC activity of GC B cells, and the overexpression of the bFcRn in 
these B cells may result in better TFH activation and thus increased 
B cell proliferation explaining the larger GCs that we observed 
in Tg spleen (Figure 9). The appropriate affinity maturation in 
Tg animals that overexpress FcRn has been demonstrated earlier, 
indicating that the affinity of the Ag-specific IgG was at least as 
good in Tg mice as in the wt controls (9). Furthermore, our recent 
antibody development projects resulted in very high-affinity mAbs 
from our bFcRn Tg mice (unpublished observation) and also from 
our FcRn Tg rabbits that have similar phenotype to the bFcRn Tg 
mice (11). Thus, we believe that FcRn overexpression improves 
affinity maturation and analyzing this important aspect more 
systematically is one of our most important goals.
Another potential outcome of the larger and many more GCs 
is that the Tg mice may develop increased diversity of Ag-specific 
antibodies. It was previously demonstrated that the number of 
activated T helper cells strongly influences the number of B cell 
clones that seeds GCs (45). Another aspect of the competition 
between activated B cells is that B cells that have higher Ag-affinity 
BCR uptake and present more Ag-specific peptide–MHC class 
II complex to cognate T helper cells than those that have lower 
Ag-affinity BCR when GC formation is initiated. Since there are 
generally limited number of cognate T helper cells, only those B 
cells receive T helper cell stimulus and seed GCs that have high-
affinity BCR. This interclonal competition was detectable over 
a wide range of Ag doses and it was also shown that increased 
number of Ag-specific T helper cells lead to an overall increase of 
high- and low-affinity B cell activation and proliferation indicating 
that T cell help is indeed limiting at this early stage. This study also 
revealed that increased T cell help is associated with increased GC 
occupancy (45). Thus, it is possible that the more activated T helper 
cells we found in Tg spleen lead to more founder B cells seeding 
the GCs in the bFcRn Tg mice. In parallel to this, we also detected 
many more GCs in the Tg spleen that have been formed potentially 
from different founder B cells. These data suggest greater diversity 
of Ag-specific B cells in the bFcRn Tg mice supporting our previ-
ous observation, albeit we found increased diversity at IgM, but 
not at IgG level in that study (13). We have initiated antibody 
sequencing and epitope binning protocols to analyze this issue 
more extensively and gain further information about the efficiency 
of the affinity maturation, too, in the bFcRn Tg mice.
We have already demonstrated that these bFcRn Tg mice could 
effectively induce immune response against weakly immunogenic 
antigens (12). Another important advantage would be for many 
antibody development protocols to generate mAbs at a point in 
time when only tiny amount of purified antigen is available. As 
July 2015 | Volume 6 | Article 35715
Schneider et al. bFcRn overexpression augments immune response
Frontiers in Immunology | www.frontiersin.org
referred above, the number of activated founder B cells that seed 
GCs depends primarily on the number of cognate T helper cells 
and less on the amount of Ag (45), although very low dose of 
antigen frequently results in non-responsiveness. To analyze this 
relatedness, we immunized Tg and wt mice with high, medium, 
and very low amount of TNP-KLH and analyzed their efficiency 
to develop Ag-specific immune responses. As expected, we found 
that the bFcRn Tg mice produced significantly higher level of 
Ag-specific IgG titers, and their superior immune response was 
demonstrated by their immune response capability to produce 
antibodies even when very low amount of Ag (three times 0.5 μg 
per mouse) was used (Figure  10). This could be advantageous 
to develop antibodies against of recombinant proteins or other 
unique antigens that are difficult to produce.
We concluded that immunization results in multifold-more 
activated, Ag-specific T helper cells, and significantly larger and 
more GCs in the spleen, and the ability to raise Abs against very 
low dose of Ag in bFcRn Tg mice compared with their wt controls. 
These findings suggest the advantage of these Tg mice for antibody 
development against weakly immunogenic targets (e.g., GPCR, ion 
channels) and also for broader epitope recognition.
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